HEADER HORMONE/GROWTH FACTOR RECEPTOR 20-JAN-03 1NQ1 TITLE TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE AND REDUCED TITLE 2 COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY IN THE NTERMINAL LBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYROID HORMONE RECEPTOR BETA-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: THRB OR NR1A2 OR ERBA2 OR THR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3 PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ALPHA HELICAL, LIGAND BINDING DOMAIN, HORMONE-GROWTH FACTOR RECEPTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.R.HUBER,M.DESCLOZEAUX,B.L.WEST,S.T.CUNHA-LIMA,H.T.NGUYEN, AUTHOR 2 J.D.BAXTER,H.A.INGRAHAM,R.J.FLETTERICK REVDAT 6 03-APR-24 1NQ1 1 REMARK REVDAT 5 14-FEB-24 1NQ1 1 REMARK REVDAT 4 27-OCT-21 1NQ1 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 1NQ1 1 VERSN REVDAT 2 24-FEB-09 1NQ1 1 VERSN REVDAT 1 15-APR-03 1NQ1 0 JRNL AUTH B.R.HUBER,M.DESCLOZEAUX,B.L.WEST,S.T.CUNHA-LIMA,H.T.NGUYEN, JRNL AUTH 2 J.D.BAXTER,H.A.INGRAHAM,R.J.FLETTERICK JRNL TITL THYROID HORMONE RECEPTOR-BETA MUTATIONS CONFERRING HORMONE JRNL TITL 2 RESISTANCE AND REDUCED COREPRESSOR RELEASE EXHIBIT DECREASED JRNL TITL 3 STABILITY IN THE N-TERMINAL LIGAND-BINDING DOMAIN JRNL REF MOL.ENDOCRINOL. V. 17 107 2003 JRNL REFN ISSN 0888-8809 JRNL PMID 12511610 JRNL DOI 10.1210/ME.2002-0097 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 8345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 890 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NQ1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000018096. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : BENT MONOCHROMATOR REMARK 200 OPTICS : FLAT MIRROR, BENT MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57101 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 80.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.848 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.06200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: THYROID HORMONE RECEPTOR BETA WITH TRIAC BOUND REMARK 200 (UNPUBLISHED DATA) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 700 MM SODIUM ACETATE, 100MM SODIUM REMARK 280 CACODYLATE, PH 7.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.51000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.02000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.02000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 43.51000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 103.25850 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 59.61632 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 43.51000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 253 REMARK 465 PRO A 254 REMARK 465 ILE A 255 REMARK 465 VAL A 256 REMARK 465 ASN A 257 REMARK 465 ALA A 258 REMARK 465 PRO A 259 REMARK 465 GLU A 260 REMARK 465 GLY A 261 REMARK 465 GLY A 262 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 203 CG CD OE1 OE2 REMARK 470 HIS A 210 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 217 CG CD OE1 OE2 REMARK 470 GLU A 227 CG CD OE1 OE2 REMARK 470 GLN A 235 CG CD OE1 NE2 REMARK 470 SER A 237 OG REMARK 470 GLN A 241 CG CD OE1 NE2 REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 GLU A 324 CG CD OE1 OE2 REMARK 470 GLU A 390 CG CD OE1 OE2 REMARK 470 LYS A 394 CG CD CE NZ REMARK 470 GLU A 445 CG CD OE1 OE2 REMARK 470 THR A 448 OG1 CG2 REMARK 470 GLU A 449 CG CD OE1 OE2 REMARK 470 GLU A 457 CG CD OE1 OE2 REMARK 470 ASP A 461 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 207 -37.99 -37.68 REMARK 500 ALA A 234 -142.85 -83.29 REMARK 500 SER A 237 71.18 148.06 REMARK 500 LYS A 240 93.82 96.94 REMARK 500 GLN A 241 132.20 63.08 REMARK 500 LYS A 242 -42.16 168.67 REMARK 500 LYS A 244 75.98 -111.10 REMARK 500 PHE A 245 114.70 -38.29 REMARK 500 PHE A 269 -35.51 -38.64 REMARK 500 PHE A 272 -78.32 -58.26 REMARK 500 ASN A 331 15.71 53.44 REMARK 500 GLU A 333 -69.65 -120.28 REMARK 500 VAL A 348 -8.11 -57.66 REMARK 500 MET A 379 43.24 -79.64 REMARK 500 SER A 381 3.07 -66.07 REMARK 500 ALA A 387 -64.33 -96.18 REMARK 500 LYS A 411 90.19 32.72 REMARK 500 HIS A 413 67.77 -102.42 REMARK 500 PRO A 447 -171.91 -59.88 REMARK 500 PRO A 452 149.32 -34.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4HY A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ARS A 601 DBREF 1NQ1 A 202 461 UNP P10828 THB1_HUMAN 202 461 SEQADV 1NQ1 ALA A 199 UNP P10828 CLONING ARTIFACT SEQADV 1NQ1 ALA A 200 UNP P10828 CLONING ARTIFACT SEQADV 1NQ1 MET A 201 UNP P10828 CLONING ARTIFACT SEQADV 1NQ1 GLN A 243 UNP P10828 ARG 240 ENGINEERED MUTATION SEQADV 1NQ1 ASP A 248 UNP P10828 GLU 245 CONFLICT SEQRES 1 A 263 ALA ALA MET GLU GLU LEU GLN LYS SER ILE GLY HIS LYS SEQRES 2 A 263 PRO GLU PRO THR ASP GLU GLU TRP GLU LEU ILE LYS THR SEQRES 3 A 263 VAL THR GLU ALA HIS VAL ALA THR ASN ALA GLN GLY SER SEQRES 4 A 263 HIS TRP LYS GLN LYS GLN LYS PHE LEU PRO ASP ASP ILE SEQRES 5 A 263 GLY GLN ALA PRO ILE VAL ASN ALA PRO GLU GLY GLY LYS SEQRES 6 A 263 VAL ASP LEU GLU ALA PHE SER HIS PHE THR LYS ILE ILE SEQRES 7 A 263 THR PRO ALA ILE THR ARG VAL VAL ASP PHE ALA LYS LYS SEQRES 8 A 263 LEU PRO MET PHE CYS GLU LEU PRO CYS GLU ASP GLN ILE SEQRES 9 A 263 ILE LEU LEU LYS GLY CYS CYS MET GLU ILE MET SER LEU SEQRES 10 A 263 ARG ALA ALA VAL ARG TYR ASP PRO GLU SER GLU THR LEU SEQRES 11 A 263 THR LEU ASN GLY GLU MET ALA VAL THR ARG GLY GLN LEU SEQRES 12 A 263 LYS ASN GLY GLY LEU GLY VAL VAL SER ASP ALA ILE PHE SEQRES 13 A 263 ASP LEU GLY MET SER LEU SER SER PHE ASN LEU ASP ASP SEQRES 14 A 263 THR GLU VAL ALA LEU LEU GLN ALA VAL LEU LEU MET SER SEQRES 15 A 263 SER ASP ARG PRO GLY LEU ALA CYS VAL GLU ARG ILE GLU SEQRES 16 A 263 LYS TYR GLN ASP SER PHE LEU LEU ALA PHE GLU HIS TYR SEQRES 17 A 263 ILE ASN TYR ARG LYS HIS HIS VAL THR HIS PHE TRP PRO SEQRES 18 A 263 LYS LEU LEU MET LYS VAL THR ASP LEU ARG MET ILE GLY SEQRES 19 A 263 ALA CYS HIS ALA SER ARG PHE LEU HIS MET LYS VAL GLU SEQRES 20 A 263 CYS PRO THR GLU LEU PHE PRO PRO LEU PHE LEU GLU VAL SEQRES 21 A 263 PHE GLU ASP HET 4HY A 500 21 HET ARS A 600 1 HET ARS A 601 1 HETNAM 4HY [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC HETNAM 2 4HY ACID HETNAM ARS ARSENIC FORMUL 2 4HY C14 H9 I3 O4 FORMUL 3 ARS 2(AS) HELIX 1 1 ALA A 199 GLY A 209 1 11 HELIX 2 2 THR A 215 THR A 232 1 18 HELIX 3 3 ASP A 265 ILE A 275 1 11 HELIX 4 4 ILE A 275 LYS A 289 1 15 HELIX 5 5 LEU A 290 GLU A 295 1 6 HELIX 6 6 PRO A 297 VAL A 319 1 23 HELIX 7 7 THR A 337 GLY A 344 1 8 HELIX 8 8 GLY A 347 LEU A 360 1 14 HELIX 9 9 ASP A 366 MET A 379 1 14 HELIX 10 10 VAL A 389 LYS A 411 1 23 HELIX 11 11 HIS A 416 CYS A 446 1 31 HELIX 12 12 PRO A 452 PHE A 459 1 8 SHEET 1 A 3 LYS A 244 PHE A 245 0 SHEET 2 A 3 MET A 334 VAL A 336 1 O ALA A 335 N LYS A 244 SHEET 3 A 3 LEU A 328 LEU A 330 -1 N LEU A 330 O MET A 334 LINK SG CYS A 434 AS ARS A 600 1555 1555 3.06 LINK SG CYS A 434 AS ARS A 601 6765 1555 3.15 SITE 1 AC1 11 ILE A 276 MET A 313 ALA A 317 ARG A 320 SITE 2 AC1 11 LEU A 330 ASN A 331 GLY A 344 ILE A 353 SITE 3 AC1 11 HIS A 435 MET A 442 PHE A 455 SITE 1 AC2 2 ASP A 427 CYS A 434 SITE 1 AC3 1 CYS A 434 CRYST1 68.839 68.839 130.530 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014527 0.008387 0.000000 0.00000 SCALE2 0.000000 0.016774 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007661 0.00000